| |
 |
Inhibition of PI3K/Akt Signaling: An Emerging Paradigm for Targeted Cancer Therapy
|
| |
|
pp.575-589 (15) Authors: Y. L. Chen, P.- Y. Law, H. H. Loh |
| |
|
|
| |
|
Lanthanides as Anticancer Agents
|
| |
|
pp.591-602 (12) Author: I. Kostova |
| |
|
|
| |
|
Current Drug Therapy for Prostate Cancer: An Overview
|
| |
|
pp.603-612 (10) Authors: A. B. Stewart, B. A. Lwaleed, D. A. Douglas, B. R. Birch |
| |
|
|
| |
|
Sulfo-Quinovosyl-Acyl-Glycerol (SQAG), a Eukaryotic DNA Polymerase Inhibitor and Anti-Cancer Agent
|
| |
|
pp.613-625 (13) Authors: Y. Mizushina, N. Kasai, H. Iijima, F. Sugawara, H. Yoshida, K. Sakaguchi |
| |
|
|
| |
|
Lycopene: A Review of Its Potential as an Anticancer Agent
|
| |
|
pp.627-635 (9) Authors: V. Bhuvaneswari, S. Nagini |
| |
|
|
| |
|
Selenium Derivatives as Cancer Preventive Agents
|
| |
|
pp.637-652 (16) Author: T. Aboul-Fadl |
| |
|
|
